Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study.
Graillon T, Ferrer L, Siffre J, Sanson M, Peyre M, Peyrière H, Mougel G, Autran D, Tabouret E, Figarella-Branger D, Barlier A, Kalamarides M, Dufour H, Colin T, Chinot O.
Graillon T, et al. Among authors: chinot o.
Neuro Oncol. 2021 Jul 1;23(7):1139-1147. doi: 10.1093/neuonc/noab019.
Neuro Oncol. 2021.
PMID: 33556177
Free PMC article.
Clinical Trial.